NeoGenomics EVP reports tax-withholding share disposition
NeoGenomics EVP, GC & Business Development Alicia C. Olivo reported updated equity holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NeoGenomics EVP, GC & Business Development Alicia C. Olivo reported updated equity holdings in the company. The filing shows a disposition of 1,042 shares of common stock on May 1, 2026 as a tax-withholding transaction, leaving her with 92,182 common shares held directly.
Alongside these shares, she holds a range of equity awards in the form of restricted stock units, performance stock units and stock options tied to NeoGenomics common stock, with various exercise prices and expiration dates, reflecting a substantial, long-term incentive position rather than open-market trading activity.
Insider Trade Summary
Exercise Price or Tax Liability: 1,042 shares
Exercise Price or Tax Liability
18 txns
Insider
Olivo Alicia C
Role
EVP, GC & Business Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,042 | $0.00 | $0.00 |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Common Stock — 92,182 shares (Direct);
Stock Option (Right to Buy) — 406,386 contracts (Direct);
Performance Stock Unit — 44,838 contracts (Direct);
Restricted Stock Unit — 205,500 contracts (Direct)
Footnotes (19)
- F1. On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F2. On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F3. On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F4. On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F5. On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F6. On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F7. On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F8. On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
- F9. Once vested, the shares of common stock are not subject to expiration.
- F10. On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F11. On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F12. On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- F13. On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F14. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
- F15. On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F16. On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F17. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.
- F18. On March 1, 2026, Ms. Olivo was granted 147,804 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F19. On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Key Figures
Tax-withholding shares: 1,042 shares
Common shares held: 92,182 shares
Stock options 2036: 147,804 shares at $10.81
+4 more
7 metrics
Tax-withholding shares
1,042 shares
Common stock delivered for tax liability on May 1, 2026
Common shares held
92,182 shares
Direct NeoGenomics common stock holdings after transactions
Stock options 2036
147,804 shares at $10.81
Options to buy common stock expiring March 1, 2036
Stock options 2035
107,450 shares at $13.05
Options to buy common stock expiring February 21, 2035
RSUs March 2026 grant
89,013 underlying shares
Restricted stock units vesting over three years from March 1, 2026
RSUs February 2025 grant
63,238 underlying shares
Restricted stock units vesting over three years from February 21, 2025
PSUs February 2024 grant
25,330 units (up to 37,996 shares)
Performance stock units tied to share and revenue goals
Key Terms
Restricted Stock Unit, Performance Stock Unit, premium-price stock option, tax-withholding disposition, +1 more
5 terms
Restricted Stock Unit financial
"On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Performance Stock Unit financial
"On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance."
A performance stock unit is a type of reward companies give to employees, usually managers, that depends on how well the company performs over time. If the company hits specific goals, the employee earns shares of stock, like earning a prize for reaching certain levels in a game. It motivates employees to work hard because their rewards are tied to the company's success.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
weighted average price financial
"based on the weighted average price of the Company's common stock over the 20-day trailing trading period"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did NeoGenomics (NEO) report for Alicia C. Olivo?
NeoGenomics reported that EVP, GC & Business Development Alicia C. Olivo had 1,042 common shares withheld on May 1, 2026 to satisfy tax obligations. After this tax-related disposition, she directly held 92,182 NeoGenomics common shares plus multiple outstanding equity awards.
What stock options does Alicia C. Olivo have according to this NeoGenomics (NEO) filing?
The filing lists several stock option grants, including 147,804 underlying shares at an exercise price of $10.81 expiring March 1, 2036, and 107,450 underlying shares at $13.05 expiring February 21, 2035. Additional smaller option grants have higher or lower exercise prices and nearer expirations.
What restricted stock units and performance stock units are reported for NeoGenomics (NEO) executive Alicia C. Olivo?
Olivo’s reported equity awards include 89,013 underlying common shares from restricted stock units granted March 1, 2026 and 63,238 from restricted stock units granted February 21, 2025. She also holds performance stock units, including 25,330 units granted February 23, 2024 tied to share-price and revenue goals.
How are NeoGenomics (NEO) performance stock units structured for Alicia C. Olivo?
Performance stock units granted to Olivo vest based on specific company goals. A 25,330-unit grant can vest up to 37,996 shares, with half tied to share growth based on weighted average price and half tied to cumulative fiscal-year revenue targets, all requiring continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates